The Hottest Tech Trend Of 2022 – PRNewswire

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary
News provided by
Nov 03, 2021, 08:00 ET
Share this article
LONDON, Nov. 3, 2021 /PRNewswire/ — It’s an industry that will never retire or ever go obsolete. It’s a revolutionary virtual marketplace, and it’s one of the fastest-growing markets on the planet. Mentioned in today’s commentary includes: Microsoft Corporation (NASDAQ:MSFT), Amazon.com, Inc. (NASDAQ:AMZN), International Business Machines Corporation (NYSE:IBM), Intel Corporation (NASDAQ:INTC), Blackberry Limited (NYSE:BB).
The world has gone full-on mobile, and nothing is nothing anymore without an app. The global mobile app sector generated over $365 billion in revenue in 2018 …In just a year-and-a-half, it will exceed $935 billion in revenue via paid downloads and in-app advertising. And the medical app industry is likely to follow suit.
Currently, there are over 1 billion Web MD searches a year, while Google receives more than a billion healthcare questions every single day…and for good reason. What most people don’t know is that multi-billion-dollar medical apps are the next big trend in healthcare.
Healthcare apps are a $390 billion market… and growing, fast. Indeed, studies have shown that mobile healthcare apps have many potential benefits, such as improving a patient’s overall wellness, reducing hospital readmissions, decreasing patient costs and ER visits, and helping patients manage chronic conditions.
And thanks to massive advances in artificial intelligence (AI)…the "doctor on your phone app" model has become significantly more effective. It is arguably, now, better than the doctor, which makes the market for healthcare powered by AI breathtakingly huge. And one little-known company has developed the most personalized, intelligent healthcare AI app to date.
Medical Apps Could Change Everything

Treatment.com International Inc. (TRUE; TREIF), a highly disruptive healthcare technology company, is harnessing the power of AI to help us improve our health.
After six years of intense research and collaborative work from a global team of doctors, engineers, mathematicians, and AI specialists, Treatment delivered the unique Global Library of Medicine, The global library of medicine is a tri level architecture with limitless applications in healthcare. Treatment.com has just unveiled its bleeding-edge AI-powered healthcare app, CARA, trained to think like a doctor.
Modern healthcare presents a big problem in need of a big solution. Google fields 1 billion health-related questions a day, or about 70,000 every minute. But it can sometimes be a minefield of misinformation, that is—for better or worse–"accessible to everyone".
Treatment.com seeks to change all that thanks to the Global Library of Medicne and cutting-edge AI app, CARA. Using the latest artificial intelligence and machine learning, paired with a global team of doctors, Treatment.com has created an engine that can assess symptoms and provide a probable diagnosis with the same reasoning approach as a trained doctor—or, in this case, a team of 40 decorated doctors from around the world.
Treatment.com’s Global Library of Mediicine driven AI has the ability to process thousands of data points and analyze a patient’s symptoms, making CARA, Treatment’s Digital Assistantideal for supporting consumer healthcare decisions, and integrating it all into the medical industry to improve cost and efficiency.
For six years, Treatment.com International has been quietly working behind the scenes to develop the CARA app. The company’s access to individualized health data has helped it develop deep insights, trends and predictions that will be invaluable to insurance providers and governments in the quest to provide better health services.
Using the massive Global Library of Medicine, the CARA Digital Health Assistant has been so effective that the University of Minnesota Medical School has licensed it to test medical students! Treatment.com intends to leverage its healthcare AI to build a multi-billion-dollar business.
Luckily, the company is well positioned to do exactly that thanks to its highly scalable and diversified revenue streams. Even better, CARA is capable of scaling massively—and rapidly.  It’s the reason why the market values Treatment.com (TRUE; TREIF) at approximately $130 million — just five years after its founding.
Big Tech Is Betting Big On Healthcare
Microsoft Corporation  (NASDAQ:MSFT) has also created new infrastructure to help provide telehealth services and other virtual offerings. "We’re introducing new Microsoft Dynamics 365 patient access features to streamline virtual experience for patients by allowing more flexibility in self-scheduling both virtual and in-person appointments through their existing patient portal and integrating virtual health assistants, like the Azure Health Bot service, for triaging, scheduling, and making it seamless to receive follow-up and wellness guidance from their care team," Tom McGuinness, Corporate Vice President, Worldwide Health, at Microsoft explained in a company blog post.
Amazon.com, Inc. (NASDAQ:AMZN)  is another tech giant that is taking a multi-pronged approach to the world’s growing needs. Amazon is also dipping its toes into the healthcare realm with Amazon Care. Initially deployed to help provide Amazon employees and their families with access to immediate high quality medical care through the use of chat and video conference capabilities, the project is now heading to other businesses looking to take care of their employees during these tough times.

Amazon.com, Inc  hasn’t stopped there, either. The company is also on the cutting edge of artifical intelligence and machine learning in the healthcare realm. Using Amazon’s cloud infrastructure, AWS,  companies will be able to make sense of health data, increase the pace of innovation and build new solutions on a trusted platform that will help keep vulnerable data safe and individuals’ privacy as a top priority. This infrastructure could set a new standard in healthcare practices that will likely last for decades to come.

International Business Machines Corporation (NYSE:IBM) is a multinational information technology company headquartered in Armonk, New York. IBM manufactures and markets computer hardware and software, and offers infrastructure services such as hosting data centers for corporate IT networks. The company also provides financing to help buy the products of other companies.
IBM’s Watson Health is a platform that includes artificial intelligence, blockchain technology data and analytics to support clients’ growing digital needs. Watson Health provides solutions to clinicians, govements, and even researchers. Innovations like this will help keep even old school tech giants like IBM relevant for years to come.

Intel Corporation (NASDAQ:INTC) is a semiconductor company that manufactures and sells computer chips, which are fundamental components in most modern computers. In recent years, Intel has been focusing on expanding its market share from PCs to smartphones and tablets. They have also been trying to get into the wearable technology space with their new "Curie" module for smartwatches and other small devices.
Intel Corporation also has significant influence in the healthcare sector, as well. In particular, in the advancement of artificial intelligence in fields such as medical imaging, analytics, and lab and life sciences. Recently, Intel Corporation embarked on a new joint venture with GE in order to pursuethe creation of a new company focused on telehealth and independent living in order to tackle the burden of chronic disease and age-related conditions. 
Intel President and CEO Paul Otellini explained, "New models of care delivery are required to address some of the largest issues facing society today, including our aging population, increasing healthcare costs and a large number of people living with chronic conditions."

You may remember Blackberry cell phones, but what you might not know is that Blackberry Limited (NYSE:BB) is one of Canada’s most exciting tech plays. While it has pivoted away from its iconic cell phones of the past, it is still very much involved in pushing technology further. It’s even building a global digitized healthcare database leveraging blockchain technology. This could be a game-changer for how health data is managed and distributed. But that’s just one facet of its big picture push. From its high-profile partnerships with the likes of Amazon and more, to its key posturing in the Internet of Things explosion, BlackBerry is tackling the industry from all fronts, and will be an important player for years to come.

BlackBerry also launched a new research and development arm called BlackBerry Advanced Technology Labs. "Today’s cybersecurity industry is rapidly advancing and BlackBerry Labs will operate as its own business unit solely focused on innovating and developing the technologies of tomorrow that will be necessary for our sustained competitive success, from A to Z; Artificial Intelligence to Zero-Trust environments," Charles Eagan, BlackBerry CTO explained.

By. Stacy graham

** IMPORTANT NOTICE AND DISCLAIMER — PLEASE READ CAREFULLY! **
Advertisement: GlobalInvestmentDaily.com and its owners, managers, employees, and assigns (collectively "the Publisher") is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Treatment.com International Inc.
("Treatment.com" or "Company") to conduct investor awareness advertising and marketing. Treatment.com paid the Publisher four hundred and fifty thousand US dollars to produce and disseminate four articles profiling the Company. This compensation should be viewed as a major conflict with our ability to be unbiased. 
Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur.
This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by Treatment.com) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP. The Publisher owns shares and / or options of the featured company and therefore has an additional incentive to see the featured company’s stock perform well. The Publisher does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The Publisher will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.
FORWARD LOOKING STATEMENTS. This publication contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this publication include, but are not limited to, the size and anticipated growth of the market for the companies’ products, the prospects for success of the Company’s to be launched health and wellness app – "CARA", the reported scheduled release of CARA, the ability to acquire customers for CARA, and the projected growth and profit margins of the Company’s core product offerings.  Factors that could cause results to differ include, but are not limited to, the companies’ ability to fund its capital requirements in the near term and long term, the management team’s ability to effectively execute its strategy, the degree of success of the launch of CARA, competition, market saturation, pricing pressures, etc. The forward-looking information contained herein is given as of the date hereof and we assume no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.
INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://GlobalInvestmentDaily.com/Terms-of-Use. If you do not agree to the Terms of Use http://GlobalInvestmentDaily.com/Terms-of-Use, please contact GlobalInvestmentDaily.com to discontinue receiving future communications.
INTELLECTUAL PROPERTY. GlobalInvestmentDaily.com is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders.  The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.
DISCLAIMER:  GlobalInvestmentDaily.com is Source of all content listed above.  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with GlobalInvestmentDaily.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by GlobalInvestmentDaily.com are solely those of GlobalInvestmentDaily.com and are not shared by and do not reflect in any manner the views or opinions of FNM.  FNM is not liable for any investment decisions by its readers or subscribers.  FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was not compensated by any public company mentioned herein to disseminate this press release.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact
e-mail:  [email protected]
U.S. Phone: +1(954)345-0611
SOURCE GlobalInvestmentDaily.com
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source